Achieve Life Sciences, Inc.
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Seattle, WA
ACHV chart
What traders are saying about $ACHV
Latest postsAchieve Life Sciences, Inc. news
- Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving Average - What's Next?
MarketBeat ·
- H.C. Wainwright reiterates Achieve Life Sciences stock rating on trial data
Investing.com ·
- Achieve Life Sciences, Inc. Estimates – NASDAQ:ACHV
TradingView ·
- Achieve Life Sciences reports 52-week cytisinicline quit rates in smokers
StreetInsider ·
- Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
Yahoo Finance ·
- Achieve Life Sciences (NasdaqCM:ACHV) Stock Forecast & Analyst Predictions
Simply Wall Street ·
- Lisata adds biopharma finance veteran Jeffrey Farrow to board
proactiveinvestors.com ·
- Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
Yahoo Finance ·
- Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
Yahoo Finance ·
- Achieve Life Sciences Announces Granting of New Hire Inducement Awards
Yahoo Finance ·
- Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
Yahoo Finance ·
- Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
Yahoo Finance ·
Achieve Life Sciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$54.6M | -$39.8M | -$29.8M | -$42.4M |
| Diluted EPS | $-1.25 | $-1.24 | $-1.50 | $-4.00 |
| Total assets (year end) | $41.8M | $38.6M | $19.4M | $30.0M |
| Cash and equivalents (year end) | $20.9M | $12.8M | $15.5M | $24.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Achieve Life Sciences, Inc.
- Ticker
- ACHV (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Seattle, WA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 949858
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Frequently asked questions
What exchange is Achieve Life Sciences, Inc. listed on?
Achieve Life Sciences, Inc. trades on the Nasdaq under the ticker symbol ACHV.
What industry is Achieve Life Sciences, Inc. in?
Achieve Life Sciences, Inc. is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Achieve Life Sciences, Inc. headquartered?
Achieve Life Sciences, Inc.'s business address on file with the SEC is in Seattle, WA.
When does Achieve Life Sciences, Inc.'s fiscal year end?
Achieve Life Sciences, Inc.'s fiscal year ends on December 31.
How much revenue did Achieve Life Sciences, Inc. report?
Achieve Life Sciences, Inc. reported $0 in revenue for calendar year 2019, according to its SEC filings.